FXYD6 Knockout HCT 116 Cell Line
Cat.No.:
EDC08292
Species:
Human
Cell Name:
HCT 116
Gene:
FXYD6
Gene ID:
53826
Size:
1×10⁶ cells
FXYD6 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08292 |
|---|---|
| Product Name | FXYD6 Knockout HCT116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | FXYD6 |
| NCBI Gene ID | |
| Gene Synonyms | - |
| Summary |
This gene encodes a member of the FXYD family of transmembrane proteins. This particular protein encodes phosphohippolin, which likely affects the activity of Na,K-ATPase. Multiple alternatively spliced transcript variants encoding the same protein have been described. Related pseudogenes have been identified on chromosomes 10 and X. Read-through transcripts have been observed between this locus and the downstream sodium/potassium-transporting ATPase subunit gamma (FXYD2, GeneID 486) locus.[provided by RefSeq, Feb 2011]
|
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4, 2days |
| Complete Culture Medium | mcCoy5A + 10% FBS |
| Freezing Medium | 90% FBS / Complete culture medium + 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying FXYD6 function, FXYD6 Knockout HCT 116 Cell Line or FXYD6 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying FXYD6 in a complementary epithelial cancer background for cross-validation of FXYD6-dependent phenotypes. The Knockout line in HCT 116 is appropriate for asking whether FXYD6 is required for Na⁺/K⁺-ATPase modulation in colorectal cancer context. Overexpression is useful for studying FXYD6 in heterologous expression contexts.
For FXYD6 research, the EDITGENE FXYD6 Knockout in HCT 116 provides a cancer epithelial cell background for cross-validation. This product complements the parallel FXYD6 Knockout in HEK293 (also available); cross-background validation strengthens characterization of FXYD6-dependent phenotypes. Rescue with wild-type FXYD6 is the standard specificity control. The knockout is valuable for studying FXYD6 in epithelial Na⁺/K⁺-ATPase regulation.
What are the application scenarios for this model?
Primary applications:
• Cross-background validation: parallel analysis with the FXYD6 Knockout in HEK293 (also available) to confirm context-independent FXYD6 functions.
• Epithelial Na⁺/K⁺-ATPase modulation: in colorectal epithelial context, characterization of FXYD6's role in epithelial ion homeostasis.
• Structure-function rescue: rescue with wild-type or specific FXYD6 variants for systematic functional dissection.
• Discovery proteomics: interactome analysis in FXYD6-null versus rescued cells.
EDITGENE recommends this HCT 116-based model for cross-validation of FXYD6 functions in epithelial cancer context.
Is this FXYD6 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. FXYD6 rescue experiments in HCT 116 are well-suited for epithelial cross-validation:
• Construct design: same considerations as FXYD6/HEK293 rescue — preserve membrane topology and FXYD motif.
• Surface localization validation: confirm plasma membrane localization before functional assays.
• Cross-background comparison: rescue in HCT 116 alongside HEK293 enables confirmation of context-independent FXYD6 functions.
• Functional readout: rescue should restore Na⁺/K⁺-ATPase modulation in epithelial context.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.